U.S. markets close in 4 hours 52 minutes
  • S&P 500

    4,400.52
    -18.63 (-0.42%)
     
  • Dow 30

    34,999.51
    -85.02 (-0.24%)
     
  • Nasdaq

    14,682.92
    -95.35 (-0.65%)
     
  • Russell 2000

    2,236.87
    -3.16 (-0.14%)
     
  • Crude Oil

    73.53
    -0.09 (-0.12%)
     
  • Gold

    1,826.50
    -9.30 (-0.51%)
     
  • Silver

    25.57
    -0.21 (-0.82%)
     
  • EUR/USD

    1.1864
    -0.0032 (-0.27%)
     
  • 10-Yr Bond

    1.2290
    -0.0400 (-3.15%)
     
  • GBP/USD

    1.3907
    -0.0051 (-0.37%)
     
  • USD/JPY

    109.7480
    +0.2870 (+0.26%)
     
  • BTC-USD

    38,936.14
    -1,037.12 (-2.59%)
     
  • CMC Crypto 200

    923.57
    -26.33 (-2.77%)
     
  • FTSE 100

    7,035.87
    -42.55 (-0.60%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

Surging Earnings Estimates Signal Upside for Kodiak Sciences Inc. (KOD) Stock

Kodiak Sciences Inc. (KOD) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

The upward trend in estimate revisions for this company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Kodiak Sciences Inc. There has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

For the current quarter, the company is expected to earn $2.19 per share, which is a change of +976% from the year-ago reported number.

Over the last 30 days, one estimate has moved higher for Kodiak Sciences Inc. compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 576.09%.

Current-Year Estimate Revisions

The company is expected to earn $0.92 per share for the full year, which represents a change of +138.33% from the prior-year number.

There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for Kodiak Sciences Inc. versus no negative revisions. This has pushed the consensus estimate 175.1% higher.

Favorable Zacks Rank

Thanks to promising estimate revisions, Kodiak Sciences Inc. currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

While strong estimate revisions for Kodiak Sciences Inc. have attracted decent investments and pushed the stock 104.2% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Kodiak Sciences Inc. (KOD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research